MGMT and cancer: Since FM-HCR reporters have been successfully transfected into both primary cells and cancer cells [17], and the NR-1 probe is amenable to any cells from which lysates can be derived [16], both approaches could potentially be used for studies of MGMT activity in cancerous and normal tissue.